After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.

One Application Seeks European Commission Authorization; Other Application Would Facilitate Availability in Low- and Lower-Middle-Income Countries - - Both Applications Will Be Assessed in Parallel ...

Gilead Sciences is undervalued, with a Buy rating and a DCF-based target price of $141, implying 13.4% upside. Click here to ...

The Trump-Vance administration took office on Jan. 20, 2025. The White House proceeded to dismantle the U.S. Agency for International Development, which funded LGBTQ and intersex rights organizations ...

The “enormous revelation” that drugs can be used to prevent catching HIV has benefitted millions and helped slash ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...